Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma.
Kim CG, Sim NS, Kim JE, Yun KH, Lee YH, Kim SH, Baek W, Han YD, Kim SK, Kim JH, Koh YW, Jung I, Shin SJ, Rha SY, Ahn JH, Kim HS.
Kim CG, et al. Among authors: kim sh, kim sk, kim je, kim hs, kim jh.
Clin Cancer Res. 2022 Aug 2;28(15):3225-3234. doi: 10.1158/1078-0432.CCR-22-0518.
Clin Cancer Res. 2022.
PMID: 35583824
Clinical Trial.